AstraZeneca’s Phase I / II Covid-19 vaccine trial unlikely to report convincing protection data

Press/Media: Research

Period	Aug 27 2020

Media coverage

Title	AstraZeneca’s Phase I / II Covid-19 vaccine trial unlikely to report convincing protection data
Media name/outlet	Pharmaceutical Technology
Country/Territory	United States
Date	27/8/20
URL	https://www.pharmaceutical-technology.com/comment/astrazeneca-covid-19-vaccine-trial/
Persons	Ira Longini